primary dysmenorrhea. primary dysmenorrhea
Conditions
Interventions
Intervention 1: Intervention group: taking capsules containing 500 mg Iranian borage (Echium amoenum) every 12 hours, from onset of menstrual pain for 72 hours or until the pain relief for three conse
Treatment - Drugs
Intervention group: taking capsules containing 500 mg Iranian borage (Echium amoenum) every 12 hours, from onset of menstrual pain for 72 hours or until the pain relief for three consecutive cycles
Control group: taking placebo capsules every 12 hours, from onset of menstrual pain for 72 hours or until the pain relief for three consecutive cycles
Sponsors
Vice chancellor for research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) single; 2) age between 18 and 30 years; 3) regular menstrual periods with interval of 21 to 35 days; 4) moderate to severe menstrual pain (above 4.4 mm in 10 cm VAS) over the past 6 months; 5) lack of heavy menstrual bleeding Exclusion criteria: 1) any sensitivity to herbal medicines; 2) smoking or alcohol drinking; 3) any known chronic diseases; 4) no easy access to telephone line for the follow-ups
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Life Enjoyment and Satisfaction. Timepoint: 1) one cycle before intervention 2) The third cycle after intervention. Method of measurement: Quality of Life Enjoyment and Satisfaction questionnaire.;Number of Gelofen used. Timepoint: 1) one cycle before intervention 2) The first , second and third cycles after intervention. Method of measurement: Visual analogue scale (VAS) for pain.;Menstural pain intensity. Timepoint: 1) one cycle before intervention 2) The first, second and third cycles after intervention. Method of measurement: Visual Analog scale ((VAS?0-10). | — |
Secondary
| Measure | Time frame |
|---|---|
| Menstural Symptom Severity. Timepoint: 1) one cycle before intervention 2) The first cycle, the second and third after intervention. Method of measurement: Symptom Severity Scale.;Menstrual blood loss. Timepoint: 1) one cycle before intervention 2) The first cycle, second and third cycles after intervention. Method of measurement: Chart Higham.;Side effects. Timepoint: The first cycle, the second and third after intervention. Method of measurement: Self report on a diary.;Satisfaction with treatment. Timepoint: The first cycle, the second and third after intervention. Method of measurement: self report- one likert question. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarideh Quick
Midwifery Department, Nursing & Midwifery Faculty, Tabriz University of Medical Sciences
Outcome results
None listed